A
ALong
JM: Back to an old recommendation LONGCurrently 7.5 % Div.Yield... From the Wykhoff view during the year a really huuuuuge cause developed with a target above 360.
Long
Short
Long
Gap Close in Fingerprint. 16.7 SEK I see a trend shift in fingerprint with raising bottoms and tops. Today we broke a range formation under high volume, so i think there is a good risk reward buying Fingerprint Cards now.
I do have shares in Fingerprint Cards and trading is under own responsibility
This is just a thought not a buy or sell recommendation
FLong
Short
Volvo Short-SETUP! WHAT A R-R-R!#High-potentialHey tradomaniacs,
great chance that we are facing now!
WHAT A CRAZY Risk-REWARD-Ratio! All I`m concerend about is the fact that VOLVO-Stock seems to love the October!
If we break out of this pattern - DAMN BUY!
As soon as we bounce off that double-resistance it`s more likely that we`ll see the market going down!
Type: Swingtrade
Stop-loss: 163,-
Sell: 158,-
Target1: 150,-
Target 2: 137,9
Let`s see what happens! :-)
Both scenarios are very nice chances!
Peace and good
Short
Short
Short
Potenial swing play im looking at BUFABOMXSTO:BUFAB Entry target around 102ish
Looking to split up my entries between
102-100ish.
Cover 40% at 105 if sucessful
Move Stop Loss, let it ride
Cover rest 108-109.5
Stop Loss bellow 99
Long
Markets can be beautifully unpredictable.On the 10th of September H&M signalled a strong bottom. This was a good sign to open a long position.
Didn't work immediately giving a bit of doubt, but the patient ones got rewarded.
7 days later it jumped 20%
Entry: 121
Exit: 135
Return: 11.5%
Long
FINGERPRINT STEAMROLLERWeekly squeeze..
Volume increasing..
Untested levels..
Get on the train booys
FLong
Auriant MiningLook for Buy setups in the 2.00-2.20 Area . Has big potential to at least hit the first target @16 level , even go a more than that to a second target around ~20 area .
ALong
Eolus VindLooking for a bounce on the trend line before making purchase the RS line trending down is also a worry
Lets discuss the latest clinical trial report Lund Sweden, July 31, 2018 –Active Biotech (NASDAQ OMX NORDIC: ACTI) today provided an update regarding the clinical development of laquinimod by Teva Pharmaceutical Industries Ltd. The Phase 2 LEGATO-HD trial evaluating the safety and efficacy of laquinimod as a treatment in Huntington’s disease (HD) did not meet its primary endpoint of change from baseline after 12 months of treatment, as measured by the Unified Huntington’s Disease Rating Scale – Total Motor Score (UHDRS-TMS). The study’s sec
Emerging patternThis stock had been consolidating after a drop during earning releases but their consensus is still over 360-380 swedish crowns. It's looking like now it has formed a bull flag and should soon trade over 340 if the pattern completes.
Long
Husqvarna B, Buy at Breakout ? Huge BB width, Postive Divergence and MACD Crossover, Good short term edge,
Long
Gomspace 3 month viewI expect we will see a further drop down to close the gap, which will be my buy zone.
This would also be the 78% retracement, lets see how i pans out.
Happy trading
Long
Long